Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

An open-label study of 12 individuals with severe treatment-resistant depression found that their symptoms significantly ...

The clinical, cardiovascular and neuroendocrine profile of ampreloxetine showed target engagement of residual peripheral autonomic neurons and a sustained standing blood pressure effect, which is ...